These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27110893)

  • 1. Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled Trials.
    Baumann L; Dayan S; Connolly S; Silverberg N; Lei X; Drinkwater A; Gallagher CJ
    Dermatol Surg; 2016 May; 42(5):598-607. PubMed ID: 27110893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines.
    Carruthers J; Rivkin A; Donofrio L; Bertucci V; Somogyi C; Lei X; Davis PG; Campo A; Beddingfield FC
    Dermatol Surg; 2015 Jun; 41(6):702-11. PubMed ID: 25993609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subject satisfaction with onabotulinumtoxinA treatment of glabellar and lateral canthal lines using a new patient-reported outcome measure.
    Rivers JK; Bertucci V; McGillivray W; Muhn C; Rosen N; Solish N; Weichman BM; Wheeler S; Daniels SR; Gallagher CJ
    Dermatol Surg; 2015 Aug; 41(8):950-9. PubMed ID: 26218728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OnabotulinumtoxinA (Botox) in the Treatment of Crow's Feet Lines in Japanese Subjects.
    Harii K; Kawashima M; Furuyama N; Lei X; Hopfinger R; Lee E
    Aesthetic Plast Surg; 2017 Oct; 41(5):1186-1197. PubMed ID: 28733805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of onabotulinumtoxinA for the treatment of crows feet lines: a multicenter, randomized, controlled trial.
    Carruthers A; Bruce S; de Coninck A; Connolly S; Cox SE; Davis PG; Campo A; Lei X; Somogyi C; Lee E; McLean H; Beddingfield F
    Dermatol Surg; 2014 Nov; 40(11):1181-90. PubMed ID: 25347451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, Efficacy, and Patient Satisfaction With OnabotulinumtoxinA for the Treatment of Upper Facial Lines in Japanese Subjects.
    Kawashima M; Harii K; Horiuchi Y; Seidman E; Lei X; Hopfinger R; Lee E
    Dermatol Surg; 2020 Apr; 46(4):483-490. PubMed ID: 31517663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines.
    De Boulle K; Werschler WP; Gold MH; Bruce S; Sattler G; Ogilvie P; Street J; Larsen KE; Yushmanova I; Lei X; Lee E; Vitarella D; Mao C
    Dermatol Surg; 2018 Nov; 44(11):1437-1448. PubMed ID: 30096106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/III Clinical Trial to Evaluate the Safety and Efficacy of a New Botulinum Toxin (HU-014) Versus OnabotulinumtoxinA in Subjects With Moderate-to-Severe Crow's Feet Lines.
    Han HS; Yoo KH; Lee JS; Huh CH; Kwon SH; Lee YW; Kim BJ
    Dermatol Surg; 2021 Apr; 47(4):e127-e131. PubMed ID: 33795571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OnabotulinumtoxinA for Simultaneous Treatment of Upper Facial Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Study.
    Rivkin AZ; Ogilvie P; Dayan S; Yoelin SG; Weichman BM; Garcia JK
    Dermatol Surg; 2020 Jan; 46(1):50-60. PubMed ID: 30829771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Patient Satisfaction for up to 6 Months With OnabotulinumtoxinA Treatment for Upper Facial Lines.
    Cohen JL; Fagien S; Ogilvie P; De Boulle K; Carruthers J; Cox SE; Kelly R; Garcia JK; Sangha S
    Dermatol Surg; 2022 Nov; 48(11):1191-1197. PubMed ID: 36342250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OnabotulinumtoxinA: a meta-analysis of duration of effect in the treatment of glabellar lines.
    Glogau R; Kane M; Beddingfield F; Somogyi C; Lei X; Caulkins C; Gallagher C
    Dermatol Surg; 2012 Nov; 38(11):1794-803. PubMed ID: 23106853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OnabotulinumtoxinA for Treatment of Moderate to Severe Crow's Feet Lines: A Review.
    Carruthers A; Bruce S; Cox SE; Kane MA; Lee E; Gallagher CJ
    Aesthet Surg J; 2016 May; 36(5):591-7. PubMed ID: 26979457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, Patient-Reported Outcomes, and Safety in Male Subjects Treated With OnabotulinumtoxinA for Improvement of Moderate to Severe Horizontal Forehead Lines.
    Keaney TC; Cavallini M; Leys C; Rossi A; Drinkwater A; Manson Brown S; Garcia JK; Mao C
    Dermatol Surg; 2020 Feb; 46(2):229-239. PubMed ID: 31343446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial.
    Moers-Carpi M; Carruthers J; Fagien S; Lupo M; Delmar H; Jones D; Somogyi C; Lee E; Lei X; MacKinnon S; Davis PG; Yalamanchili R; Campo A; Beddingfield FC
    Dermatol Surg; 2015 Jan; 41(1):102-12. PubMed ID: 25485803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
    Ascher B; Rzany BJ; Grover R
    Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow's Feet: A Phase 3, Multicenter, Randomized, Double-Blind, Split-Face Study.
    Cheon HI; Jung N; Won CH; Kim BJ; Lee YW
    Dermatol Surg; 2019 Dec; 45(12):1610-1619. PubMed ID: 30893169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OnabotulinumtoxinA for Treatment of Forehead and Glabellar Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Double-Blind Study.
    Ogilvie P; Rivkin AZ; Dayan S; Yoelin SG; Weichman BM; Garcia JK
    Dermatol Surg; 2019 May; 45(5):689-699. PubMed ID: 31034447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of OnabotulinumtoxinA for Treatment of Crow's Feet Lines in Chinese Subjects.
    Wu Y; Wang G; Li C; Mao C; Lei X; Lee E
    Plast Reconstr Surg Glob Open; 2019 Jan; 7(1):e2079. PubMed ID: 30859038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of OnabotulinumtoxinA treatment for crow's feet lines on patient-reported outcomes.
    Dayan S; Coleman WP; Dover JS; De Boulle K; Street J; Romagnano L; Daniels S; Kowalski JW; Lei X; Lee E
    Dermatol Surg; 2015 Jan; 41 Suppl 1():S67-74. PubMed ID: 25548848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of crow's feet lines and forehead lines with Botox (onabotulinumtoxinA): Development, insights, and impact.
    Carruthers A; Carruthers J; De Boulle K; Lowe N; Lee E; Brin MF
    Medicine (Baltimore); 2023 Jul; 102(S1):e32496. PubMed ID: 37499083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.